The International Journal for Experimental and Clinical Reproductive Immunobiology
Guide for Authors
Online Submission is now available and we encourage all authors to use this service at http://ees.elsevier.com/jri.
Types of Papers
(1) Full-length papers, generally not exceeding 3000 words of text with up to 4 figures and 4 tables
(or equivalent).
(2) Short communications not exceeding 1500 words or equivalent space including figures, tables and references.
These must be brief definitive reports and not preliminary findings.
(3) Reviews will be published following invitation
from an Editor-in-Chief or Section Editor.
(4) Other articles (eg. Opinion Papers) are welcomed, but must include new data/concepts.
(5) Letters to the Editors (not exceeding 500 words).
All submissions other than Letters are subject to stringent peer-review procedures.
The Editors-in-Chief wish to emphasise their preference for both clarity and conciseness in presentation style of manuscripts. Announcements
of meetings, courses and book reviews will
be included at the discretion of the Editors and the Publisher.
Submission of a
paper to the Journal of Reproductive Immunology implies (i) that it is not being submitted for publication elsewhere and(ii)
the transfer of the copyright from the authors to the Publishers. If you are not submitting online,then the original manuscript
together with two full copies should be submitted to one of the Editors-in-Chief: Professor Peter M. Johnson, Department of
Immunology, University of Liverpool, Daulby Street, Liverpool L69 3GA, UK. Tel: (+44)151 706 4354, Fax: (+44)151 706 5814; E-mail: jri@liv.ac.uk Professor D. Ware Branch, D. Ware Branch, Department of Obstetrics and Gynecology, University of Utah Hospitals, 50 North Medical
Drive, Room 2B200, Salt Lake City, Utah 84132, USA. Tel: +1 (801) 581 7931, Fax: +1 (801) 585 2594, E-mail: wareb@aol.com
Professor Shigeru Saito, Department of Obstetrics and Gynecology, University of Toyama, 2630 Sugitani, Toyama 930-0194, JAPAN.
Tel: (81) 76 434 7355, Fax: (81) 76 434 5036, Email: jri@med.u-toyama.ac.jp
Manuscripts in English should be
typed in double spacing with wide margins, on one side of paper only and should be accompanied by a separate title page bearing names
and affiliations of authors, as well as a full postal address for correspondence together with fax:e-mail number
if appropriate. Authors
wishing to take advantage of anonymous refereeing should submit the original complete manuscript plus two copies with just the authors'
names and affiliations removed from the title page.
Full-length papers must be divided into an Abstract (not exceeding
250 words) that summarises the problem, the major results and conclusion,Key Words (3-6 items), followed by
Introduction:
This should give the reasons for the study, but not an extensive review of all previous work in the area.
Materials and Methods:
This should be concise but with sufficient detail to allow the work to be repeated. Where appropriate, reference to previous published
methodology should be made in place of reiteration of experimental detail.
Results: These should be given in a brief
and concise form. The method on which any statistical evaluation is based should be stated.
Discussion: The significance
of the results should be discussed in relation to other works and not just recapitulated.
Subheadings should be numerically
labelled within each section. Any Acknowledgements should be placed immediately after the text, and prior
to the Reference
list.
Short communications should not be divided into sections, but should have a brief Abstract and a list
of no more than 20 references.
Abbreviations should be explained at their first occurrence. Unusual abbreviations should
be avoided, as should abbreviations of ordinary
words.
Tables/Figures/Artwork: If you are submitting Online, please review
information on how to prepare your artwork for electronic submission at:http://www.elsevier.com/artworkinstructions
Tables must be typed double-spaced on separate sheets, numbered consecutively with Arabic numerals, and only contain horizontal
lines. A short descriptive title should appear above each table, with possible legend and footnotes (identified with a, b, c, etc.) below.
Figures should be very sharp, well-contrasting and suitable for immediate reproduction. High quality computer-generated figures
are preferred. Any patterns or shadings must be dark enough for reproduction and must be distinguishable from each other. Half-tone figures
should be
in black-and-white, very sharp, well-contrasting, and on glossy paper. Lettering should be large enough to permit photographic
reproduction. All legends should be typed double-spaced on separate sheets. Reproduction in colour needs to be approved by the Editors;
the extra cost will be charged to the author(s). Colour Reproductions are currently at no charge, with the agreement of the Editors and
Publisher as to their appropriateness.
All figures and tables should be comprehensible without reference to the text. A list of figures
and tables must accompany the manuscript. Each
figure should be marked on the back with the figure number and the first author's name.
Where there is any doubt as to the orientation,
the top should be marked with an arrow on the back of the figure.
References
should be assembled on a separate sheet(s) and only relevant papers cited; exhaustive lists should be avoided. Normally, full-length
papers should cit no more than 40 references. In the text, references should be cited by author and year (Harvard System). More than
one paper from the same author in the same year must be identified separately by the letters a, b, c, etc. placed after the year of publication.
In the text, when referring to a work by more than two authors,
the name of the first author should be given followed by et al. In the
reference list, citation of periodical, book or multi-author book articles should comply with the following examples:
Saito, S., Sasaki,
Y., Sakai, M., 2005. CD4+CD25high regulatory T cells in human pregnancy. J. Reprod. Immunol. 65, 111-120.
Anderson, D.J., 1996. Interaction between male genital tract infection,
immunity and infertility. In: Bronson, R.A. et al. (Eds.), Reproductive
Immunology. Blackwell, Cambridge, MA, pp. 532-539.
Abbreviations
of journal titles should conform to the current edition of Index Medicus. Only papers that have been published or accepted for
publication (in press) should be listed in the references; unpublished observations and personal communications should be cited as such
in the
text.
The Editors reserve the right to make literary corrections and will request a final approved manuscript to be accompanied
by a matching electronic disk.
Conflict of interest
All authors must disclose any financial and personal relationships
with other people or organisations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest
include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or
other funding.
Role of the funding source
All sources of funding should be declared as an acknowledgement at the end
of the text. Authors should declare the role of study sponsors, if any, in the collection, analysis and interpretation of data and in
the writing of the manuscript. If the study sponsors had no such involvement, the authors should so state.
Proofs will be
sent to the author to check for type-setting accuracy and must be returned within 48 hours. No changes or additions to the
original manuscript
will be allowed at this stage.
Page charges None.
Reprints may be ordered by completing and returning to the Publishers
the order form sent to the authors with their proofs. Twenty-five free reprints per contribution will be forwarded to the corresponding
author.
Funding body agreements and policies Elsevier has established agreements and developed policies to allow authors whose
articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions
of their grant awards. To learn more about existing agreements and policies please visit http://www.elsevier.com/fundingbodies
